You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The San Diego-based genome mapping firm's share price fell below $1.00 for 30 consecutive days, triggering a noncompliance notification from Nasdaq.
The investment bank said the company's molecular diagnostics have the potential to replace microarrays for cytogenetics analysis.
The acquisition will allow the firms to provide annotated biospecimens, as well as sequencing, bioinformatics, and lab services to hospitals and clinicians.
Through the new lab, NeoGenomics can work with pharmaceutical clients through the different phases of drug development, including the development of companion diagnostics.
As part of the deal, Genetics' cytogenetics training facility — one of five accredited cytogenetics training facilities in the US — will be transferred to Poplar.
The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.